Nab-paclitaxel combined with oxaliplatin and S-1 as conversion therapy for advanced gastric adenocarcinoma. Phase 2 study of cabozantinib (cabo) and pembrolizumab (pembro) in metastatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results